THE COST EFFECTIVENESS OF GOLIMUMAB AS AN ADD-ON TO CONVENTIONAL CARE COMPARED TO CC FOR THE TREATMENT OF NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS IN SCOTLAND
Abstract
Authors
R.H. Borse E. McCann O. McGill C.M. Black S. Kachroo R.P. Insinga